Arellano, LE, Willett, JM, Borry, P. International survey on attitudes toward ethics in health technology assessment: An exploratory study. Int J Technol Assess Health Care. 2011;27:50–54.
Wallay, T. Health technology assessment in England: Assessment and appraisal. Med J Aust. 2007;187:283–285.
Putnam, H. The collapse of the fact/value dichotomy and other essays. Cambridge, MA: Harvard University Press; 2002.
Hennen, L. Biomedical and bioethical issues in parliamentary TA and in health technology assessment. Poiesis Prax. 2004;2:207–220.
Flyvbjerg, B. Making social science matter: Why social inquiry fails and how it can succeed again. Cambridge: University of Cambridge; 2001.
Meggle, G, Nida-Rümelin, J (Eds.). [Actions, norms, values: Discussions with Georg Henrik von Wright]. Berlin: de Gruyter; 1999.
Molewijk, B, Stiggelbout, AM, Otten, W, Dupuis, HM, Kievit, J. Implicit normativity in evidence-based medicine: A plea for integrated empirical ethics research. Health Care Anal. 2003;11:69–92.
Hofmann, B. Toward a procedure for integrating moral issues in health technology assessment. Int J Technol Assess Health Care. 2005;21:312–318.
Hofmann, B. On value-judgements and ethics in health technology assessment. Poiesis Prax. 2005;3:277–295.
Nord, E. Cost-value analysis in health care: Making sense out of QALYs. Cambridge: Cambridge University Press; 1999.
Cookson, R, Drummond, M, Weatherly, H. Explicit incorporation of equity considerations into economic evaluation of public health interventions. Health Econ Policy Law. 2009;4
Johri, M, Norheim, OF. Can cost-effectiveness analysis integrate concerns for equity? Systematic review. Int J Technol Assess Health Care. 2012;28:125–132.
Culyer, AJ. Perspective and desire in comparative effectiveness research: The relative unimportance of mere preferences, the central importance of context. Pharmacoeconomics. 2010;28:889–897.
Schwappach, DL. Resource allocation, social values and the QALY: A review of the debate and empirical evidence. Health Expect. 2002;5:210–222.
Burls, A, Caron, L, de Langavant, GC, et al.
Tackling ethical issues in health technology assessment: A proposed framework. Int J Technol Assess Health Care. 2011;27:230–237.
Droste, S, Rixen, S. [Information on legal issues in health technologies: Methodological proposal to identify them in a systematic and comprehensible manner]. Z Evid Fortbild Qual Gesundhwes. 2012;106:509–522.
Hofmann, B. Why ethics should be part of health technology assessment. Int J Technol Assess Health Care. 2008;24:423–429.
Velasco Garrido, M, Borlum Kristensen, F, Palmhoj Nielsen, C, Busse, R. Health technology assessment and health policy-making in Europe. Geneva: World Health Organization on behalf of the European Observatory on Health Systems and Policies; 2008.
Green, C. Considering the value associated with innovation in health technology appraisal decisions (deliberations): A NICE thing to do?
Appl Health Econ Health Policy. 2010;8:1–5.
Oortwijn, WJ, van der Wilt, GJ. [Distributive justice and health technology assessment in the Netherlands: Analysis of six projects funded within the Fund for Investigative Medicine]. Nijmegen: Universitair Medisch Centrum St Radboud, Afdeling MTA; 2003.
Tunis, SR. Reflections on science, judgment, and value in evidence-based decision making: A conversation with David Eddy. Health Aff (Millwood). 2007;26:w500–w515.
Hoedemaekers, R, Oortwijn, W. Problematic notions in Dutch health care package decisions. Health Care Anal. 2003;11:287–294.
Klein, R, Day, P, Redmayne, S. Managing scarcity: Priority setting and rationing in the National Health Service. Buckingham: Open University Press; 1996.
Bombard, Y, Abelson, J, Simeonov, D, Gauvin, FP. Eliciting ethical and social values in health technology assessment: A participatory approach. Soc Sci Med. 2011;73:135–144.